All Stories

  1. Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program

    Article • Clinical Trials, March 2019, SAGE Publications

    Dr Christopher B Granger

  2. OUP accepted manuscript

    Article • European Heart Journal, January 2019, Oxford University Press (OUP)

    Dr Christopher B Granger

  3. Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

    Article • Journal of the American Heart Association, September 2017, Wolters Kluwer Health

    Prof Ralph A Stewart, Professor Claes Held, Dr Christopher B Granger

  4. Assessing generalizability of trial results in general practice

    Article • European Heart Journal, October 2015, European Society of Cardiology

    Dr Christopher B Granger

  5. Should patients on vitamin K antagonists be treated differently?

    Article • European Heart Journal, February 2015, European Society of Cardiology

    Dr Christopher B Granger

  6. Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

    Article • American Heart Journal, January 2015, Elsevier

    Dr Christopher B Granger

  7. Improving diabetes medication adherence: successful, scalable interventions

    Article • Patient Preference and Adherence, January 2015, Taylor & Francis

    Dr Christopher B Granger

  8. Regional systems of care demonstration project: Mission: Lifeline STEMI Systems Accelerator: Design and methodology

    Article • American Heart Journal, January 2014, Elsevier

    Dr Christopher B Granger